Human Reproduction, Vol. 14, No. 3, 807-815,
March 1999
© 1999 European Society of Human Reproduction and Embryology
Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B)*
1 Prince Henry's Institute of Medical Research, PO Box 5152, Clayton, Victoria 3168, Australia, 2 Monash University Dept. of Obstetrics and Gynaecology, Clayton, Victoria 3168, Australia and 3 Human Reproduction Study Group, Department of Obstetrics and Gynaecology, University of Indonesia, Klinik Raden Salah, Jalan Raden Salah 49, Jakarta, 10330, Indonesia
Norplant, subdermally implanted slow-release levonorgestrel, is an effective and widely used contraceptive agent but has a high rate of discontinuation due to unacceptable abnormal uterine bleeding. Matrix metalloproteinases (MMPs) are expressed in normal cycling endometrium and are postulated to be responsible for the tissue breakdown at menstruation. We have compared the immunolocalization of MMP-9 and migratory cells in endometrium from Indonesian women using Norplant with normal controls. Positive MMP-9 immunostaining was observed intracellularly within stromal and intravascular leukocytes and extracellularly in areas of tissue lysis adjacent to these migratory cells. The MMP-9 positive cells were identified as neutrophils, eosinophils, CD3+ T-cells and macrophages. Quantitative assessment revealed that the number of MMP-9 positive cells, neutrophils and eosinophils were significantly increased in those endometrial biopsies from Norplant users displaying a shedding morphology and in normal controls at menstruation. There was no correlation between the number of MMP-9 positive cells and the number of bleeding days reported. Endometrial immunostaining for tissue inhibitor of metalloproteinases was similar in Norplant users and normal controls. These results suggest that MMP-9, an enzyme capable of degrading basement membrane components, may be involved in endometrial breakdown in women using Norplant.
Key words: : endometrial bleeding/immunochemistry/leukocyte/matrix metalloproteinase-9/Norplant
*Parts of this work were presented in abstract form at the 28th Australian Society for Reproductive Biology Meeting, 1997 (abstract 60) and the 45th Society for Gynecological Investigation Meeting, 1998 (abstract 305).
4 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women Reproduction, January 1, 2007; 133(1): 309 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peloggia, C. A. Petta, L. Bahamondes, M. Oliveira-Ribeiro, J. Zhang, and L. Salamonsen Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system Hum. Reprod., May 1, 2006; 21(5): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wahab, A.H. Taylor, J.H. Pringle, J. Thompson, and F. Al-Azzawi Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell Mol. Hum. Reprod., March 1, 2006; 12(3): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jones, J. K. Findlay, P. G. Farnworth, D. M. Robertson, E. Wallace, and L. A. Salamonsen Activin A and Inhibin A Differentially Regulate Human Uterine Matrix Metalloproteinases: Potential Interactions during Decidualization and Trophoblast Invasion Endocrinology, February 1, 2006; 147(2): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jones, N. B. Morison, N. J. Hannan, H. O.D. Critchley, and L. A. Salamonsen Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations Hum. Reprod., October 1, 2005; 20(10): 2724 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kaitu'u, J. Shen, J. Zhang, N. B. Morison, and L. A. Salamonsen Matrix Metalloproteinases in Endometrial Breakdown and Repair: Functional Significance in a Mouse Model Biol Reprod, October 1, 2005; 73(4): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Hannan, R. L. Jones, H. O. D. Critchley, G. J. Kovacs, P. A. W. Rogers, B. Affandi, and L. A. Salamonsen Coexpression of Fractalkine and Its Receptor in Normal Human Endometrium and in Endometrium from Users of Progestin-Only Contraception Supports a Role for Fractalkine in Leukocyte Recruitment and Endometrial Remodeling J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6119 - 6129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oliveira-Ribeiro, C. A. Petta, L. A.L. De Angelo Andrade, L. Bahamondes, and M. M. Hidalgo Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system Hum. Reprod., August 1, 2004; 19(8): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galant, M. Berliere, D. Dubois, J.-C. Verougstraete, A. Charles, P. Lemoine, I. Kokorine, Y. Eeckhout, P. J. Courtoy, and E. Marbaix Focal Expression and Final Activity of Matrix Metalloproteinases May Explain Irregular Dysfunctional Endometrial Bleeding Am. J. Pathol., July 1, 2004; 165(1): 83 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brasted, C.A. White, T.G. Kennedy, and L.A. Salamonsen Mimicking the Events of Menstruation in the Murine Uterus Biol Reprod, October 1, 2003; 69(4): 1273 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey and I.S. Fraser Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding Hum. Reprod., September 1, 2002; 17(9): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum. Reprod., May 1, 2002; 17(5): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ancelin, H. Buteau-Lozano, G. Meduri, M. Osborne-Pellegrin, S. Sordello, J. Plouet, and M. Perrot-Applanat A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus PNAS, April 30, 2002; 99(9): 6023 - 6028. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galant, M. Vekemans, P. Lemoine, I. Kokorine, P. Twagirayezu, P. Henriet, C. Picquet, V. Rigot, Y. Eeckhout, P. J. Courtoy, et al. Temporal and Spatial Association of Matrix Metalloproteinases with Focal Endometrial Breakdown and Bleeding upon Progestin-Only Contraception J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4827 - 4834. [Abstract] [Full Text] |
||||
![]() |
R.L. Jones, L.A. Salamonsen, H.O.D. Critchley, P.A.W. Rogers, B. Affandi, and J.K. Findlay Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception Mol. Hum. Reprod., December 1, 2000; 6(12): 1107 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Lathbury and L. A. Salamonsen In-vitro studies of the potential role of neutrophils in the process of menstruation Mol. Hum. Reprod., October 1, 2000; 6(10): 899 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey, D. Dwarte, and I.S. Fraser Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding Hum. Reprod., July 1, 2000; 15(7): 1509 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brechin, S.T. Cameron, A.M. Paterson, A.R. Williams, and H.O.D. Critchley Intrauterine polyps--a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: Case Report Hum. Reprod., March 1, 2000; 15(3): 650 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, L. J. Lathbury, and L. A. Salamonsen Expression of the Chemokine Eotaxin and Its Receptor, CCR3, in Human Endometrium Biol Reprod, February 1, 2000; 62(2): 404 - 411. [Abstract] [Full Text] |
||||
![]() |
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives Hum. Reprod., January 1, 2000; 15(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, A. L. Hampton, G. Nie, and L. A. Salamonsen Progesterone Inhibits Activation of Latent Matrix Metalloproteinase (MMP)-2 by Membrane-Type 1 MMP: Enzymes Coordinately Expressed in Human Endometrium Biol Reprod, January 1, 2000; 62(1): 85 - 94. [Abstract] [Full Text] |
||||
![]() |
M. Ancelin, H. Buteau-Lozano, G. Meduri, M. Osborne-Pellegrin, S. Sordello, J. Plouet, and M. Perrot-Applanat A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus PNAS, April 30, 2002; 99(9): 6023 - 6028. [Abstract] [Full Text] [PDF] |
||||








